Product Information

OXCARBAZEPINE 300 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.1714 per EA under NDC 62559022101. Its NADAC has been published 63 times since Sep 3, 2025.

FDA first approved this application on Dec 11, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OXCARBAZEPINE 300 MG TABLET

Oxcarbazepine
$0.1714per EA

Strength

300 mg/1

NDC

62559022101

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

OXCARBAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA078005

FDA Approved

12/11/2007

TE Code

AB

On Market Since

7/15/2025

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for OXCARBAZEPINE 300 MG TABLET has been published 63 times since Sep 3, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.1714 per EA
All-time high$0.1747 (Sep 10, 2025)
All-time low$0.1635 (Jul 22, 2026)
52-week high$0.1745
52-week low$0.1635
Median price$0.1691
Average price$0.1692
Largest weekly change+2.8% (Oct 21, 2026)
Weeks tracked63
Tracking sinceSep 3, 2025

Price History

1W

0.0%

1M

+2.8%

3M

+4.8%

6M

+2.2%

1Y

-0.3%

3Y

N/A

5Y

N/A

All

-1.9%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OXCARBAZEPINE 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.1714 per EA (NDC 62559022101), effective Nov 11, 2026.

How has the price of OXCARBAZEPINE 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG TABLET has held within roughly two percent of its current level. It has been tracked across 63 weekly CMS publications since Sep 3, 2025.

What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG TABLET?

Since Sep 3, 2025, the NADAC for OXCARBAZEPINE 300 MG TABLET has ranged from a low of $0.1635 (Jul 22, 2026) to a high of $0.1747 (Sep 10, 2025), with a median of $0.1691 per EA.

Are there cheaper alternatives to OXCARBAZEPINE 300 MG TABLET?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXCARBAZEPINE 300 MG TABLET, is $0.1691 per EA — about 1% below OXCARBAZEPINE 300 MG TABLET.

Who manufactures OXCARBAZEPINE 300 MG TABLET?

OXCARBAZEPINE 300 MG TABLET (NDC 62559022101) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.